Ben Barnes
7 Papers
Ben Barnes is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 6 publications.
Chat about Author
Papers
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
James F. Howard,Saskia Bresch,Angela Genge,Channa Hewamadduma,John L. Hinton,Yessar Hussain,Raul Juntas-Morales,Henry J. Kaminski,Angelina H. Maniaol,Renato Mantegazza,Masayuki Masuda,Kumaraswamy Sivakumar,Marek Śmiłowski,Kimiaki Utsugisawa,Tuan Vu,Michael D. Weiss,Małgorzata Zajda,Babak Boroojerdi,Melissa Brock,Petra Duda,Mark Vanderkelen,Maria Isabel Leite,Jeanne Teitelbaum,Michael W. Nicolle,Emilien Bernard,Juliette Svahn,Marco Spinazzi,Tanya Stojkovic,Sophie Demeret,N. Weiss,Loïc Le Guennec,Christine Tranchant,Aleksandra Nadaj-Pakleza,Jean-Baptiste Chanson,M. Suliman,Céline Tard,Jana Zschüntzsch,Jens Schmidt,Stefanie Glaubitz,Rachel Zeng,M D Scholl,Markus C. Kowarik,U. Ziemann,Markus Krumbholz,Pascal Martin,Christoph Ruschil,Jutta Dünschede,Benjamin Berger,Andreas Totzeck,Tim Hagenacker,Benjamin Stolte,Raffaele Iorio,Amelia Evoli,Silvia Falso,Carlo Antozzi,Rita Frangiamore,Fiammetta Vanoli,Elena Rinaldi,Kazushi Deguchi,Naoya Minami,Yuriko Nagane,Yasushi Suzuki,Sayaka Ishida,Shigeaki Suzuki,Jin Nakahara,Shunsuke Yoshimura,Shingo Konno,Akiyuki Uzawa,Tomoya Kubota,Masanori Takahashi,Tatsusada Okuno,Hiroyuki Murai,Nils Erik Gilhus,Marion I. Boldingh,T. H. Rønning,U. Chyrchel-Paszkiewicz,Klaudiusz Kumor,Tomasz Zielinski,Krzysztof Banaszkiewicz,Michal Blaż,Agata Klosek,Mariola Świderek-Matysiak,Andrzej Szczudlik,A. Pasko,Lech Szczechowski,Marta Banach,Jan Ilkowski,Solangel Garcia,Ana Segura,J. T. Sans,N. Fernández,Elena Cortes Vicente,P. R. Armenteros,Mohammad R. Ashraghi,Ana Cavey,A P. Emery,K.L. Liow,Sharon Yegiaian,Alexandru Barboi,R.M. Vazquez,Joshua Lennon,Robert M. Pascuzzi,Cynthia Bodkin,Sandy Guingrich,Adam Comer,C. Bromberg,Teresa Janecki,S Saba,M. Tellez,Bakri Elsheikh,Miriam Freimer,Sarah Heintzman,Raghav Govindarajan,Jeffrey T. Guptill,Janice M. Massey,Vern C. Juel,Natalia Sanchez Gonzalez,Ali A. Habib,Tahseen Mozaffar,Manisha Kak Korb,Namita Goyal,Hannah C. Machemehl,Georgios Manousakis,Jeffrey Allen,Emily Harper,Constantine Farmakidis,Mazen M. Dimachkie,Mamatha Pasnoor,Salma Akhter,Said R. Beydoun,Courtney E. McIlduff,Joan Nye,Bhaskar Roy,B. Sheldon,Richard Nowak,Ben Barnes,Michael H. Rivner,Niraja Suresh,Jessica D. Shaw,Brittany Harvey,Lucy Lam,Nikki Lynn Thomas,Manisha Chopra,Rebecca Traub,Sarah M. Jones,M. A. Wagoner,Radwa Aly,Jonathan L. Katz,Henry H. Chen,Robert G. Miller,Liberty Jenkins,Shaida Khan,Bhupen Khatri,Lisa M. Sershon,Pantelis Pavlakis,Shara Holzberg,Yuebing Li,Irys B Caristo,Roberto Marquardt,Debbie Hastings,Jacob Rube,Robert P. Lisak,Aparna Choudhury,Katherine Ruzhansky,Amit Sachdev,Susan M. Shin,Joan Bratton,Mary Fetter,Naya McKinnon,Jonathan McKinnon,Laura Sissons-Ross,Barbara J. Distad +171 more
TL;DR: Zilucoplan treatment showed rapid and clinically meaningful improvements in myasthenia gravis-specific efficacy outcomes, had a favourable safety profile, and was well tolerated, with no major safety findings.
41
ALSUntangled #67: rituximab
Xiaoyan Li,Carmel Armon,Paul E. Barkhaus,Ben Barnes,Michael Benatar,Tulio E. Bertorini,C. Bromberg,Gregory T. Carter,Jesse Crayle,Merit Cudkowicz,Mazen M. Dimachkie,Eva L. Feldman,Jonathan D. Glass,Jill Goslinga,Terry Heiman-Patterson,Sartaj Jhooty,Rachel Lichtenstein,Isaac Lund,Christopher J McDermott,Gary L. Pattee,Kaitlyn Pierce,Dylan Ratner,Kristiana Salmon,Paul Wicks,Richard Bedlack +24 more
TL;DR: A current lack of evidence for a role of these cells in ALS progression is shown, and a drug which specifically depletes B lymphocytes is advised against its use as an ALS treatment.
3
ALSUntangled # 69: astaxanthin
Timothy R Fullam,Carmel Armon,Paul E. Barkhaus,Ben Barnes,Morgan Beauchamp,Michael Benatar,Tulio E. Bertorini,Robert Bowser,C. Bromberg,J. Mascias Cadavid,Gregory T. Carter,Mazen M. Dimachkie,David L. Ennist,Eva L. Feldman,Terry Heiman-Patterson,Sartaj Jhooty,Isaac Lund,Christopher J McDermott,Gary L. Pattee,Dylan Ratner,Paul Wicks,Richard Bedlack +21 more
TL;DR: In this article , a review of alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS) is presented. But, there have been no trials of astaxanthin in patients living with ALS.
ALSUntangled #70: caffeine.
Jessica Oliver Hatch,Paul E. Barkhaus,Ben Barnes,Morgan Beauchamp,Michael Benatar,Tulio E. Bertorini,Robert Bowser,C. Bromberg,J. Mascias Cadavid,Gregory T. Carter,Jesse Crayle,Mazen M. Dimachkie,David L. Ennist,Eva L. Feldman,Timothy R Fullam,Terry Heiman-Patterson,Sartaj Jhooty,Todd Levine,Xiaoyan Li,Isaac Lund,Nicholas J. Maragakis,Christopher J McDermott,Gary L. Pattee,Kaitlyn Pierce,Dylan Ratner,Kimberlee J. Staats,Paul Wicks,Martina Wiedau,Richard Bedlack +28 more
TL;DR: In this article , the authors reviewed alternative and off-label treatments for people living with amyotrophic lateral sclerosis (PALS) and found that low doses of caffeine are safe and inexpensive, higher doses can cause serious side effects.
ALSUntangled #65: glucocorticoid corticosteroids
Jill Goslinga,Mark Terrelonge,Richard Bedlack,Paul E. Barkhaus,Ben Barnes,Tulio E. Bertorini,C. Bromberg,Gregory T. Carter,Amy Chen,Jesse Crayle,Mazen M. Dimachkie,Leanne Jiang,Gleb Levitsky,Isaac Lund,Sarah Martin,Christopher J McDermott,Gary L. Pattee,Kaitlyn Pierce,Dylan Ratner,Lenka Slachtova,Yuyao Sun,Paul Wicks +21 more
TL;DR: The review of the current evidence concludes that glucocorticoids do not offer clinical benefit in ALS and confer serious risks, and ALSUntangled does not recommend glucoc Corticoids as a treatment for ALS.